PROTAC AR-V7 degrader-1 - HY-145479
Nur noch %1 verfügbar
Catalog #
HY-145479
Ab
610,00 €
PROTAC AR-V7 degrader-1 is an orally active and selective AR-V7 PROTAC degrader with a DC50 of 0.32 μM (in 22Rv1 cells). PROTAC AR-V7 degrader-1 can inhibit the proliferation of tumor cells and exhibit anti-tumor activity. PROTAC AR-V7 degrader-1 can be used for the research of cancers such as prostate cancer[1].(Pink: VPC-14228 (HY-117669); Black: linker (HY-W041652); Blue: VHL Ligand (HY-112078))
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-145479/PROTAC-AR-V7-degrader-1-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| CAS | 2767440-24-2 |
| Storage | -20°C (Powder, protect from light) |
| MWT | 789.02 |
| Solubility | DMSO : 110 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Androgen Receptor;PROTACs |
| Application: | Cancer-programmed cell death |
|---|